Tech Company Financing Transactions

Circular Genomics Funding Round

Mountain Group Partners, Cottonwood Technology Fund and private investors participated in a $8.3 million Series A funding round for Circular Genomics. The financing round was announced on 1/24/2024.

Transaction Overview

Company Name
Announced On
1/24/2024
Transaction Type
Venture Equity
Amount
$8,300,000
Round
Series A
Investors
Proceeds Purpose
The new funding will enable Circular Genomics to build and scale commercial operations in preparation for the launch of the world's first circular RNA-based clinical assay.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
5901 Indian School Rd NE
Albuquerque, NM 87110
USA
Phone
Undisclosed
Email Address
Overview
Circular Genomics is a pioneer in precision medicine, leveraging cutting-edge technology and proprietary data to uncover insights for personalized medicine. We're dedicated to advancing circular RNA biomarkers for accurate diagnosis and treatment of psychiatric and neurological disorders, aiming to empower individuals to gain deeper insights into their mental health and discover optimal treatment pathways.
Profile
Circular Genomics LinkedIn Company Profile
Social Media
Circular Genomics Company Twitter Account
Company News
Circular Genomics News
Facebook
Circular Genomics on Facebook
YouTube
Circular Genomics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Sargeant
  Paul Sargeant LinkedIn Profile  Paul Sargeant Twitter Account  Paul Sargeant News  Paul Sargeant on Facebook
Chief Financial Officer
Stephen McKernan
  Stephen McKernan LinkedIn Profile  Stephen McKernan Twitter Account  Stephen McKernan News  Stephen McKernan on Facebook
Chief Information Officer
Kosmas Karadimitriou
  Kosmas Karadimitriou LinkedIn Profile  Kosmas Karadimitriou Twitter Account  Kosmas Karadimitriou News  Kosmas Karadimitriou on Facebook
Chief Scientific Officer
Nikolaos Mellios
  Nikolaos Mellios LinkedIn Profile  Nikolaos Mellios Twitter Account  Nikolaos Mellios News  Nikolaos Mellios on Facebook
VP - Bus. Development
Dave Karlander
  Dave Karlander LinkedIn Profile  Dave Karlander Twitter Account  Dave Karlander News  Dave Karlander on Facebook
VP - R & D
Vishi Srinivasan
  Vishi Srinivasan LinkedIn Profile  Vishi Srinivasan Twitter Account  Vishi Srinivasan News  Vishi Srinivasan on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/24/2024: HEPHAISTOS-Pharma venture capital transaction
Next: 1/24/2024: Anomalo venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary